Content deleted Content added
Vanished user 0x8cSXE0x6 (talk | contribs) No edit summary |
Vanished user 0x8cSXE0x6 (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{About|a non-clinically used compound|the pharmaceutical drug|Estramustine phosphate}} |
{{About|a non-clinically used compound|the pharmaceutical drug|Estramustine phosphate}} |
||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = |
| Verifiedfields = verified |
||
| Watchedfields = |
| Watchedfields = verified |
||
| verifiedrevid = |
| verifiedrevid = |
||
| IUPAC_name = [(8''R'',9''S'',13''S'',14''S'',17''S'')-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[''a'']phenanthren-3-yl] ''N'',''N''-bis(2-chloroethyl)carbamate |
| IUPAC_name = [(8''R'',9''S'',13''S'',14''S'',17''S'')-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[''a'']phenanthren-3-yl] ''N'',''N''-bis(2-chloroethyl)carbamate |
Revision as of 09:07, 21 September 2018
Clinical data | |
---|---|
Other names | EM; EaM; Leo 275; Ro 21-8837; Estradiol 3-(bis(2-chloroethyl)carbamate) ester; Estra-1,3,5(10)-triene-3,17β-diol 3-(bis(2-chloroethyl)carbamate) ester |
Drug class | Nitrogen mustard; Alkylating antineoplastic agent; Estrogen; Estrogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.019.161 |
Chemical and physical data | |
Formula | C23H31Cl2NO3 |
Molar mass | 440.405 g/mol g·mol−1 |
3D model (JSmol) | |
| |
|
Estramustine (INN , USAN , BAN ) is a synthetic, steroidal estrogen and cytostatic antineoplastic agent which was never marketed.[1][2] It is an estrogen ester – specifically, the C3 normustine ester of estradiol – and acts in part as a prodrug of estradiol in the body.[1][2] Estramustine phosphate, the C17β phosphate ester of estramustine, is marketed and used in the treatment of prostate cancer.[1][2]
See also
References
- ^ a b c J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 502–. ISBN 978-1-4757-2085-3.
- ^ a b c Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 406–. ISBN 978-3-88763-075-1.